Detalhe da pesquisa
1.
Real-World Use, Safety, and Patient Experience of 20% Subcutaneous Immunoglobulin for Primary Immunodeficiency Diseases.
Adv Ther
; 40(12): 5168-5187, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37751025
2.
Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease.
PLoS One
; 17(6): e0268780, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35679232